15 January 2025
15 January 2025
Zimmer Biomet anticipates that six products launched last year will come into their own throughout 2025.
The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.
Sutter Health's collaboration with GE HealthCare will focus on optimising technology and service delivery and advancing service line care.
The clearance marks the receipt of second authorisation for the company from the FDA.
The WHO has reported a “high” regional and national risk from the haemorrhagic virus while the global risk remains low.
Taking place six months post-surgery, the study reported substantial gains in best-corrected distance visual acuity (BCDVA).
The $90m will be used to launch the second of two pivotal trials examining the company’s therapy for patients living with heart failure.
The companies will partner with healthcare organisations to improve their data strategies with cloud migrations and technologies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
